In Vitro Susceptibilities Of 176 Clinical Isolates Of Streptococcus Pneumoniae to 11 Beta-Lactams, Erythromycin, and Tetracycline

References

• Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis.1992: 14801–9.
   Google Scholar
• Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992; 15: 77–83.
   Google Scholar
• Hakenbeck R, Tarpay M, Tomasz A. Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1980;17:364–71.
   Google Scholar
• Fenoll A, Bourgon CM, Mufi6z R, Vicioso D, Casal J. Serotype distribution and antimicrobial’resistance of Streptococcus pneumoniae isolates causing systemic intections in Spain, 1979–1989 Rev Infect Dis. 1991; 13:56–60.
   Google Scholar
• Marton A. Pneumococcal antimicrobial resistance: die problem in Hungary. C//w Infect Dis. 1992* 15106–11.
   Google Scholar
• Munoz R, Musscr JM, Crain M, et al. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis. 1992; 15: 112–8.
   Google Scholar
• Facklam RR, Washington IIJA. Streptococcus and related catalase-negative Gram-positive cocci. In: Balows A, Ed. Manual of Clinical Microbiology. Fifth Edition. Washington, D.C.: ASM. 1991: 238–57.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Methods fordilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. NCCLS Document M7-A3. Vol. 13 No. 25, Villanova PA, 1993.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS Document M100-S6, Vol. 15 No. 14, Villanova, PA, 1995.
   Google Scholar
• Verhaegen J, Glupczynski Y, Verbisl L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980–1993. Clin Infect Dis. 1995; 20: 1339–45.
   Google Scholar
• Ducoffre G. Surveillance van infectieuze aandoeningen door een netwerk van laboratoria voor microbiologic, 1994 + relrospectieve 1983–1993. Rapport van het Instituut voor Hygiene en Epidemiologic. December 1995: 42–6.
   Google Scholar
• Poole MD. Otitis media complications and treatment failures: implications of pneumococcal resistance. Pediatr Infect Dis J. 1995; 14: S23–6.
   Google Scholar
• Goldstein FW, Garau J. Resistant pneumococci: a renewed threat in respiratory infections. ScandJ Infect Dis. 1994; Suppl. 93: 55–62.
   Google Scholar
• Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis. 1991; 163:542–8.
   Google Scholar
• Kam KM, Luey KY, Fung SM, Yiu PP, Harden TJ, Cheung MM. Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother. 1995; 39: 2667–70.
   Google Scholar
• Mason Jr EO, Kaplan SL. Penicillin-resistant pneumococci in the United Stales. Pediatr Infect Dis J. 1995; 14: 1017–18.
   Google Scholar
• Frdmaux A, Sissia G, Rosenbaum M, Gdslin P. In vitro activity of cefpirome (HR 810) a new parenteral cephalosporin, against penicillin susceptible and resistant pneumococci. In: Program and Abstracts of the Thirty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim CA 1992. Abstract 1020 p. 280. ASM, Washington D.C.
   Google Scholar
• Spangler SK, Jacobs MR, Appelbaum PC. In vitro susceptibilities of 185 penicillin-susceptible and-resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime and cefdinir. Antimicrob Agents Chemother. 1994; 38: 2902–04.
   Google Scholar
• Pankuch GA, Jacobs MR, Appelbaum PC. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and-resistant pneumococci. J Antimicrob Chemother. 1995; 35: 883–8.
   Google Scholar
• Pankuch GA, Jacobs MR, Appelbaum PC. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparlloxacin, ciprofloxacin and vancomycin by using time-kill methodology. Antimicrob Agents Chemother. 1994;38:2065–72.
   Google Scholar